18/08/2026
To improve stability during storage, some vaccines require reconstitution before administration. medSask has recently received reports of administration errors related to preparation.
✅Before administering a vaccine:
- confirm whether reconstitution is required (e.g., Abrysvo®, Arexvy, M-M-R® II Shingrix)
- follow the product-specific preparation instructions
- use the correct diluent and volume
- double-check the final product
❗Dispensing matters too!
If a vaccine is being dispensed to be administered by another provider, consider attaching an auxiliary label noting any reconstitution requirements or advising patients to alert the provider at their appointment. A quick reminder may help prevent vaccine preparation errors.
📰Did you know? News for Shingrix:
Health Canada recently approved a new prefilled syringe presentation of Shingrix that eliminates the need for reconstitution. It’s expected to be available in early 2027. Until then, the currently available Shingrix vaccine still requires combining the antigen and adjuvant before administration.
📖Need a quick reference for vaccines requiring reconstitution?
medSask's Injectable Vaccines with Diluents chart summarizes the correct diluents, storage requirements, and time limits between reconstitution and administration for commonly used vaccines.
Check it out now!https://medsask.usask.ca/sites/medsask/files/2024-04/medSask_InjectableVaccinesDiluents_March29%2C2024.pdf